Whitepaper

CRISPR epigenetic ‘switch’ provides new way to control memory

Carrie Haslam Carrie Haslam
30 Oct 2025 0 min read

Login or Register

After logging in, you can access the full content

Author

Read Bio
Carrie Haslam
Author

For the first time, researchers have demonstrated that flipping an epigenetic ‘switch’ in memory cells can directly control whether a memory is expressed or silenced, offering new insights into how memories are stored and potentially altered.

Every experience we have leaves a mark in the brain, encoded within small clusters of cells known as engrams. These engrams are thought to hold the blueprint of a memory and become active whenever we recall it, making them a key focus for researchers studying age or trauma-related memory loss.

Researchers also know that learning is accompanied by epigenetic changes – chemical ‘notes’ that cells add to DNA to control gene activity. However, it has remained unclear whether altering the epigenetic state of a single gene could directly influence a memory.

Investigating the Arc gene

A research team led by Professor Johannes Gräff at Ecole Polytechnique Fédérale De Lausanne (EPFL) Laboratory of Neuroepigenetics combined CRISPR-based gene editing with a method that labels engram cells in mice. They concentrated on a gene called Arc, which helps neurons adjust their connections. By targeting the regulatory region of Arc, the team asked whether modifying its epigenetic ‘switch’ could alter memory.

Creating the epigenetic switch

In the study, the scientists developed CRISPR-based tools designed to either reduce or enhance Arc activity in memory neurons. Some, such as the KRAB-MeCP2 tool, switched off gene activity by adding repressive marks that make DNA less accessible, while others opened the DNA to activate the gene. These tools then acted as an epigenetic switch for Arc.

Using harmless viruses, the team delivered these tools into the hippocampus, a brain region critical for memory storage and recall.

Using harmless viruses, the team delivered these tools into the hippocampus, a brain region critical for memory storage and recall. The mice were trained to associate a specific location with a mild foot shock. By manipulating Arc’s epigenetic state in the engram cells, researchers could observe whether the animals remembered the shock. They also included a safety switch that could reverse the editing and reset the memory.

The experiments found that silencing Arc epigenetically prevented the mice from forming the memory, while boosting Arc strengthened it. Remarkably, these effects could be reversed in the same animal, showing that this switch can dial memory expression in both directions. Even memories several days old, typically resistant to change, could be modified. On a molecular level, these edits triggered changes in gene activity and DNA organisation that matched the behavioural results.

Controlling memory at the cellular level

This study gives researchers the first direct evidence that adjusting the epigenetic state of memory cells is both necessary and sufficient to control memory expression. It could lead to deeper exploration of how memories are formed, stored and modified, potentially with a view to developing therapies for humans in the future.

These approaches could help scientists better understand conditions where memory processing goes wrong, including traumatic memories in PTSD, drug-associated memories in addiction or the memory deficits seen in neurodegenerative diseases.

Related Whitepapers

Animal Models
Cancer research
Drug Discovery
Drug Targets
In Vivo
Oncology
Therapeutics
Translational Science
+7
06 November 2025

Protein FSP1 found to help melanoma survive in lymph nodes

New research has discovered a key survival mechanism in metastatic melanoma, revealing that cancer cells spreading to lymph nodes depend on a protein ...

Drug Target Review Drug Target Review
Nov 6, 2025 • 1 min read
Animal Models
Drug Development
Drug Discovery Processes
Immuno-oncology
Immunotherapy
Monoclonal Antibody
Oncology
Translational Science
+7
06 November 2025

Sugar-coated tumours: a new target for pancreatic cancer

Researchers have discovered that pancreatic tumours evade the immune system by disguising themselves with a sugar coating. To combat this, they have d...

Drug Target Review Drug Target Review
Nov 6, 2025 • 1 min read
Analysis
Computational techniques
Drug Discovery
Drug Discovery Processes
Molecular Biology
Structural Biology
Translational Science
+6
06 November 2025

RNA folding: new model could change future drug design

A Japanese research team has simulated how RNA molecules fold, using cutting-edge computational tools to model complex structures with accuracy – a br...

Drug Target Review Drug Target Review
Nov 6, 2025 • 1 min read
Central Nervous System (CNS)
Drug Targets
Enzymes
Mitochondria
Neuroprotection
Neurosciences
Pharmacology
Translational Science
+7
06 November 2025

BVRA enzyme may slow down Alzheimer’s progression

New research from Johns Hopkins Medicine reveals that the enzyme BVRA protects brain cells from oxidative stress, allowing for potential new methods f...

Drug Target Review Drug Target Review
Nov 6, 2025 • 1 min read
Cell Cultures
Disease Research
Hepatocytes
In Vitro
Induced Pluripotent Stem Cells (iPSCs)
Organoids
Regenerative Medicine
Translational Science
+7
04 November 2025

Lab-grown liver offers new platform to test fibrosis drugs

Japanese scientists have developed a lab-grown liver organoid that mimics human liver regeneration, offering a new platform to study fibrosis and test...

Drug Target Review Drug Target Review
Nov 4, 2025 • 1 min read
Assays
Bioengineering
Biomarkers
CRISPR
Disease Research
Neurosciences
RNAs
Translational Science
+7
04 November 2025

New blood test detects Alzheimer’s years before symptoms

Scientists have developed two rapid and affordable blood tests that can detect early markers of Alzheimer’s disease – potentially decades before sympt...

Drug Target Review Drug Target Review
Nov 4, 2025 • 1 min read
Animal Models
Translational Science
+1
31 October 2025

Alzheimer’s brain structure investigated through fruit flies

Scientists have used fruit flies to study 100 genes linked to Alzheimer’s disease and how these genes affect brain structure, function and stress resi...

Carrie Haslam Carrie Haslam
Oct 31, 2025 • 1 min read